Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Akari Therapeutics Plc | Director | Ordinary Shares, par value $0.0001 per share | 3.41B | Jun 30, 2024 | PranaBio Investments LLC | ||
Akari Therapeutics Plc | Director | Warrants (Right to Buy) | 1.33B | May 31, 2024 | PranaBio Investments LLC | ||
Akari Therapeutics Plc | Director | Ordinary Shares, par value $0.0001 per share | 91.4M | Jun 30, 2024 | Direct | ||
Akari Therapeutics Plc | Director | Stock Option (Right to Buy) | 79.7M | Oct 31, 2024 | Direct | ||
CytoDyn Inc. | Director | Non-qualified Stock Option | 12.3K | Nov 24, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AKTX | Akari Therapeutics Plc | Oct 31, 2024 | 1 | $0 | 4 | Nov 1, 2024 | Director |
AKTX | Akari Therapeutics Plc | Sep 30, 2024 | 1 | $0 | 4 | Oct 2, 2024 | Director |
AKTX | Akari Therapeutics Plc | Jun 30, 2024 | 1 | $0 | 4 | Jul 2, 2024 | Director |
AKTX | Akari Therapeutics Plc | May 31, 2024 | 2 | $2.39M | 4 | Jun 4, 2024 | Director |
AKTX | Akari Therapeutics Plc | Jan 1, 2024 | 0 | $0 | 3 | Jan 2, 2024 | Director |
CYDY | CytoDyn Inc. | Nov 24, 2021 | 6 | $0 | 4/A | Nov 30, 2021 | Director |
CYDY | CytoDyn Inc. | Oct 18, 2021 | 1 | $0 | 4 | Oct 20, 2021 | Director |